O	O	O	0	10	Inhibitory	Inhibitory	B-NP	JJ	O	2	NMOD	O
O	O	O	11	17	effect	effect	I-NP	NN	O	0	ROOT	O
O	O	O	18	20	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	21	26	E3330	E3330	B-NP	NN	O	8	NMOD	O
O	O	O	26	27	,	,	O	,	O	8	P	O
O	O	O	28	29	a	a	B-NP	DT	O	8	NMOD	O
O	O	O	30	35	novel	novel	I-NP	JJ	O	8	NMOD	O
O	O	O	36	43	quinone	quinone	I-NP	NN	O	3	PMOD	O
O	O	O	44	54	derivative	derivative	I-NP	NN	O	8	NMOD	O
O	O	O	55	59	able	able	B-ADJP	JJ	O	8	NMOD	O
O	O	O	60	62	to	to	B-VP	TO	O	12	VMOD	O
O	O	O	63	71	suppress	suppress	I-VP	VB	O	10	AMOD	O
T1	B-Protein	B-Protein	72	77	tumor	tumor	B-NP	NN	B-protein	15	NMOD	B-protein
T1	I-Protein	I-Protein	78	86	necrosis	necrosis	I-NP	NN	I-protein	15	NMOD	I-protein
T1	I-Protein	I-Protein	87	93	factor	factor	I-NP	NN	I-protein	18	NMOD	I-protein
T1	I-Protein	I-Protein	93	94	-	-	O	HYPH	O	18	NMOD	O
T1	I-Protein	I-Protein	94	99	alpha	alpha	B-NP	SYM	O	18	NMOD	O
O	O	O	100	110	generation	generation	B-NP	NN	O	12	OBJ	O
O	O	O	110	111	,	,	O	,	O	18	P	O
O	O	O	112	114	on	on	B-PP	IN	O	18	NMOD	O
O	O	O	115	125	activation	activation	B-NP	NN	O	20	PMOD	O
O	O	O	126	128	of	of	B-PP	IN	O	21	NMOD	O
T15	B-Entity	B-Entity	129	136	nuclear	nuclear	B-NP	JJ	B-protein	27	NMOD	B-protein
T15	I-Entity	I-Entity	137	143	factor	factor	I-NP	NN	I-protein	27	NMOD	I-protein
T15	I-Entity	I-Entity	143	144	-	-	B-NP	HYPH	I-protein	27	NMOD	I-protein
T15	I-Entity	I-Entity	144	149	kappa	kappa	I-NP	NN	I-protein	27	NMOD	I-protein
T15	I-Entity	I-Entity	150	151	B	B	I-NP	NN	I-protein	22	PMOD	I-protein
O	O	O	151	152	.	.	O	.	O	2	P	O

O	O	O	154	155	(	(	O	(	O	2	NMOD	O
O	O	O	155	157	2E	2E	B-NP	NN	O	36	NMOD	O
O	O	O	157	158	)	)	O	)	O	2	NMOD	O
O	O	O	158	159	-	-	B-NP	HYPH	O	2	P	O
O	O	O	159	160	3	3	I-NP	CD	O	2	NMOD	O
O	O	O	160	161	-	-	O	HYPH	O	2	P	O
O	O	O	161	162	[	[	O	(	O	26	DEP	O
O	O	O	162	163	5	5	O	CD	O	26	DEP	O
O	O	O	163	164	-	-	O	HYPH	O	8	P	O
O	O	O	164	165	(	(	O	(	O	26	DEP	O
O	O	O	165	166	2	2	B-NP	CD	O	25	NMOD	O
O	O	O	166	167	,	,	O	,	O	25	P	O
O	O	O	167	168	3	3	B-NP	CD	O	25	NMOD	O
O	O	O	168	169	-	-	I-NP	HYPH	O	25	P	O
O	O	O	169	178	Dimethoxy	Dimethoxy	I-NP	NN	B-protein	25	NMOD	B-protein
O	O	O	178	179	-	-	B-NP	HYPH	I-protein	15	NMOD	I-protein
O	O	O	179	180	6	6	I-NP	CD	I-protein	16	NMOD	I-protein
O	O	O	180	181	-	-	I-NP	HYPH	O	25	P	O
O	O	O	181	187	methyl	methyl	I-NP	NN	O	25	NMOD	O
O	O	O	187	188	-	-	I-NP	HYPH	O	25	P	O
O	O	O	188	189	1	1	I-NP	CD	O	25	NMOD	O
O	O	O	189	190	,	,	I-NP	,	O	25	P	O
O	O	O	190	191	4	4	I-NP	CD	O	25	NMOD	O
O	O	O	191	192	-	-	I-NP	HYPH	O	25	P	O
O	O	O	192	204	benzoquinoyl	benzoquinoyl	I-NP	NN	O	26	DEP	O
O	O	O	204	205	)	)	O	)	O	2	NMOD	O
O	O	O	205	206	]	]	O	)	O	2	NMOD	O
O	O	O	206	207	-	-	B-NP	HYPH	O	2	P	O
O	O	O	207	208	2	2	I-NP	CD	O	2	NMOD	O
O	O	O	208	209	-	-	I-NP	HYPH	O	2	P	O
O	O	O	209	214	nonyl	nonyl	I-NP	NN	O	36	NMOD	O
O	O	O	214	215	-	-	B-NP	HYPH	O	36	NMOD	O
O	O	O	215	216	2	2	I-NP	CD	O	36	NMOD	O
O	O	O	216	217	-	-	I-NP	HYPH	O	36	NMOD	O
O	O	O	218	227	propenoic	propenoic	I-NP	JJ	O	36	NMOD	O
O	O	O	228	232	acid	acid	I-NP	NN	O	41	SUB	O
O	O	O	233	234	(	(	O	(	O	39	DEP	O
O	O	O	234	239	E3330	E3330	B-NP	NN	O	39	DEP	O
O	O	O	239	240	)	)	O	)	O	36	NMOD	O
O	O	O	240	241	,	,	O	,	O	36	P	O
O	O	O	242	244	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	245	246	a	a	B-NP	DT	O	44	NMOD	O
O	O	O	247	252	novel	novel	I-NP	JJ	O	44	NMOD	O
O	O	O	253	258	agent	agent	I-NP	NN	O	41	PRD	O
O	O	O	259	263	with	with	B-PP	IN	O	44	NMOD	O
O	O	O	264	280	hepatoprotective	hepatoprotective	B-NP	JJ	O	47	NMOD	O
O	O	O	281	289	activity	activity	I-NP	NN	O	45	PMOD	O
O	O	O	289	290	.	.	O	.	O	41	P	O

O	O	O	291	293	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	294	300	report	report	B-VP	VBP	O	0	ROOT	O
O	O	O	301	304	the	the	B-NP	DT	O	4	NMOD	O
O	O	O	305	311	effect	effect	I-NP	NN	O	2	OBJ	O
O	O	O	312	314	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	315	320	E3330	E3330	B-NP	NN	O	5	PMOD	O
O	O	O	321	323	on	on	B-PP	IN	O	4	NMOD	O
O	O	O	324	339	transcriptional	transcriptional	B-NP	JJ	O	9	NMOD	O
O	O	O	340	350	activation	activation	I-NP	NN	O	7	PMOD	O
O	O	O	351	353	of	of	B-PP	IN	O	9	NMOD	O
T16	B-Entity	B-Entity	354	359	tumor	tumor	B-NP	NN	B-DNA	19	NMOD	B-DNA
T16	I-Entity	I-Entity	360	368	necrosis	necrosis	I-NP	NN	I-DNA	19	NMOD	I-DNA
T16	I-Entity	I-Entity	369	375	factor	factor	I-NP	NN	I-DNA	19	NMOD	I-DNA
T16	I-Entity	I-Entity	376	377	(	(	O	(	I-DNA	16	DEP	I-DNA
T16	I-Entity	I-Entity	377	380	TNF	TNF	B-NP	NN	I-DNA	16	DEP	I-DNA
T16	I-Entity	I-Entity	380	381	)	)	O	)	I-DNA	13	NMOD	I-DNA
T16	I-Entity	I-Entity	381	382	-	-	B-NP	HYPH	I-DNA	19	NMOD	I-DNA
T16	I-Entity	I-Entity	382	387	alpha	alpha	I-NP	NN	I-DNA	19	NMOD	I-DNA
T16	I-Entity	I-Entity	388	392	gene	gene	I-NP	NN	I-DNA	10	PMOD	I-DNA
O	O	O	393	396	and	and	B-PP	CC	O	7	PMOD	O
O	O	O	397	399	on	on	B-PP	IN	O	7	PMOD	O
T17	B-Entity	B-Entity	400	407	nuclear	nuclear	B-NP	JJ	B-protein	30	NMOD	B-protein
T17	I-Entity	I-Entity	408	414	factor	factor	I-NP	NN	I-protein	30	NMOD	I-protein
T17	I-Entity	I-Entity	415	416	(	(	O	(	I-protein	30	NMOD	I-protein
T17	I-Entity	I-Entity	416	418	NF	NF	B-NP	NN	I-protein	30	NMOD	I-protein
T17	I-Entity	I-Entity	418	419	)	)	O	)	I-protein	30	NMOD	I-protein
T17	I-Entity	I-Entity	419	420	-	-	B-NP	HYPH	I-protein	30	NMOD	I-protein
T17	I-Entity	I-Entity	420	425	kappa	kappa	I-NP	NN	I-protein	30	NMOD	I-protein
T17	I-Entity	I-Entity	426	427	B	B	I-NP	NN	I-protein	30	NMOD	I-protein
O	O	O	428	438	activation	activation	I-NP	NN	O	21	PMOD	O
O	O	O	438	439	.	.	O	.	O	2	P	O

O	O	O	440	447	Nuclear	Nuclear	B-NP	JJ	O	2	NMOD	O
O	O	O	448	451	run	run	I-NP	NN	O	6	SUB	O
O	O	O	451	452	-	-	B-ADVP	HYPH	O	2	P	O
O	O	O	452	454	on	on	B-PP	IN	O	2	NMOD	O
O	O	O	455	466	experiments	experiment	B-NP	NNS	O	4	PMOD	O
O	O	O	467	473	showed	show	B-VP	VBD	O	0	ROOT	O
O	O	O	474	478	that	that	B-SBAR	IN	O	6	VMOD	O
O	O	O	479	484	E3330	E3330	B-NP	NN	O	9	SUB	O
O	O	O	485	494	decreases	decrease	B-VP	VBZ	O	7	SBAR	O
O	O	O	495	510	transcriptional	transcriptional	B-NP	JJ	O	11	NMOD	O
O	O	O	511	521	activation	activation	I-NP	NN	O	9	OBJ	O
O	O	O	522	524	of	of	B-PP	IN	O	11	NMOD	O
T18	B-Entity	B-Entity	525	528	TNF	TNF	B-NP	NN	B-protein	16	NMOD	B-protein
T18	I-Entity	I-Entity	528	529	-	-	O	HYPH	O	16	NMOD	O
T18	I-Entity	I-Entity	529	534	alpha	alpha	O	SYM	B-DNA	16	NMOD	B-DNA
T18	I-Entity	I-Entity	535	539	gene	gene	B-NP	NN	I-DNA	12	PMOD	I-DNA
O	O	O	540	547	induced	induce	B-VP	VBN	O	16	NMOD	O
O	O	O	548	550	by	by	B-PP	IN	O	17	VMOD	O
O	O	O	551	569	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	23	NMOD	O
O	O	O	570	571	(	(	O	(	O	22	DEP	O
O	O	O	571	574	LPS	LPS	B-NP	NN	O	22	DEP	O
O	O	O	574	575	)	)	O	)	O	19	NMOD	O
O	O	O	576	587	stimulation	stimulation	B-NP	NN	O	18	PMOD	O
O	O	O	588	590	in	in	B-PP	IN	O	23	NMOD	O
O	O	O	591	596	human	human	B-NP	JJ	B-cell_type	27	NMOD	B-cell_type
O	O	O	597	607	peripheral	peripheral	I-NP	JJ	I-cell_type	27	NMOD	I-cell_type
O	O	O	608	617	monocytes	monocyte	I-NP	NNS	I-cell_type	24	PMOD	I-cell_type
O	O	O	617	618	.	.	O	.	O	6	P	O

O	O	O	619	621	To	To	B-VP	TO	O	2	VMOD	O
O	O	O	622	633	investigate	investigate	I-VP	VB	O	8	VMOD	O
O	O	O	634	637	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	638	648	inhibitory	inhibitory	I-NP	JJ	O	5	NMOD	O
O	O	O	649	659	mechanisms	mechanism	I-NP	NNS	O	2	OBJ	O
O	O	O	659	660	,	,	O	,	O	8	P	O
O	O	O	661	663	we	we	B-NP	PRP	O	8	SUB	O
O	O	O	664	675	constructed	construct	B-VP	VBD	O	0	ROOT	O
O	O	O	676	677	a	a	B-NP	DT	O	20	NMOD	O
O	O	O	678	686	secreted	secrete	I-NP	VBN	B-DNA	20	NMOD	B-DNA
O	O	O	686	687	-	-	I-NP	HYPH	I-DNA	20	NMOD	I-DNA
O	O	O	687	691	type	type	I-NP	NN	I-DNA	20	NMOD	I-DNA
T2	B-Protein	B-Protein	692	701	placental	placental	I-NP	JJ	I-DNA	20	NMOD	I-DNA
T2	I-Protein	I-Protein	702	710	alkaline	alkaline	I-NP	NN	I-DNA	20	NMOD	I-DNA
T2	I-Protein	I-Protein	711	722	phosphatase	phosphatase	I-NP	NN	I-DNA	20	NMOD	I-DNA
O	O	O	723	724	(	(	O	(	I-DNA	20	NMOD	I-DNA
T3	B-Protein	B-Protein	724	728	PLAP	PLAP	B-NP	NN	I-DNA	20	NMOD	I-DNA
O	O	O	728	729	)	)	O	)	I-DNA	20	NMOD	I-DNA
O	O	O	730	738	reporter	reporter	B-NP	NN	I-DNA	20	NMOD	I-DNA
O	O	O	739	743	gene	gene	I-NP	NN	I-DNA	8	OBJ	I-DNA
O	O	O	744	749	whose	whose	B-NP	WP$	O	22	NMOD	O
O	O	O	750	763	transcription	transcription	I-NP	NN	O	20	NMOD	O
O	O	O	764	766	is	be	B-VP	VBZ	O	22	SBAR	O
O	O	O	767	777	controlled	control	I-VP	VBN	O	23	VC	O
O	O	O	778	780	by	by	B-PP	IN	O	24	VMOD	O
O	O	O	781	782	a	a	B-NP	DT	O	36	NMOD	O
O	O	O	783	784	1	1	I-NP	CD	O	28	AMOD	O
O	O	O	784	785	.	.	I-NP	.	O	36	NMOD	O
O	O	O	785	786	4	4	I-NP	CD	O	36	NMOD	O
O	O	O	786	787	-	-	I-NP	HYPH	O	36	NMOD	O
O	O	O	787	789	kb	kb	I-NP	NN	O	36	NMOD	O
O	O	O	790	795	human	human	I-NP	JJ	O	36	NMOD	O
T4	B-Protein	B-Protein	796	799	TNF	TNF	I-NP	NN	B-protein	36	NMOD	B-protein
T4	I-Protein	I-Protein	799	800	-	-	I-NP	HYPH	O	36	NMOD	O
T4	I-Protein	I-Protein	800	805	alpha	alpha	I-NP	NN	B-DNA	36	NMOD	B-DNA
T19	B-Entity	B-Entity	806	814	promoter	promoter	I-NP	NN	I-DNA	25	PMOD	I-DNA
O	O	O	814	815	.	.	O	.	O	8	P	O

O	O	O	816	817	A	A	B-NP	DT	O	3	NMOD	O
O	O	O	818	824	stable	stable	I-NP	JJ	O	3	NMOD	O
O	O	O	825	837	transformant	transformant	I-NP	NN	O	15	SUB	O
O	O	O	838	840	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	841	844	the	the	B-NP	DT	O	8	NMOD	O
T5	B-Protein	B-Protein	845	849	PLAP	PLAP	I-NP	NN	B-DNA	8	NMOD	B-DNA
O	O	O	850	858	reporter	reporter	I-NP	NN	I-DNA	8	NMOD	I-DNA
O	O	O	859	863	gene	gene	I-NP	NN	I-DNA	4	PMOD	I-DNA
O	O	O	864	871	derived	derive	B-VP	VBN	O	8	NMOD	O
O	O	O	872	876	from	from	B-PP	IN	O	9	VMOD	O
O	O	O	877	882	human	human	B-NP	JJ	B-cell_line	14	NMOD	B-cell_line
O	O	O	883	892	monocytic	monocytic	I-NP	JJ	I-cell_line	14	NMOD	I-cell_line
O	O	O	893	897	cell	cell	I-NP	NN	I-cell_line	14	NMOD	I-cell_line
O	O	O	898	902	line	line	I-NP	NN	I-cell_line	10	PMOD	I-cell_line
O	O	O	903	909	showed	show	B-VP	VBD	O	0	ROOT	O
O	O	O	910	914	very	very	B-NP	RB	O	17	AMOD	O
O	O	O	915	921	little	little	I-NP	JJ	O	18	NMOD	O
O	O	O	922	930	activity	activity	I-NP	NN	O	15	OBJ	O
O	O	O	931	933	on	on	B-PP	IN	O	18	NMOD	O
O	O	O	934	937	the	the	B-NP	DT	O	21	NMOD	O
O	O	O	938	946	promoter	promoter	I-NP	NN	B-DNA	19	PMOD	B-DNA
O	O	O	947	953	before	before	B-PP	IN	O	18	NMOD	O
O	O	O	954	965	stimulation	stimulation	B-NP	NN	O	22	PMOD	O
O	O	O	965	966	,	,	O	,	O	15	P	O
O	O	O	967	974	whereas	whereas	O	IN	O	15	VMOD	O
O	O	O	975	978	LPS	LPS	B-NP	NN	O	27	NMOD	O
O	O	O	979	990	stimulation	stimulation	I-NP	NN	O	28	SUB	O
O	O	O	991	994	led	lead	B-VP	VBD	O	25	SBAR	O
O	O	O	995	997	to	to	B-PP	TO	O	28	VMOD	O
O	O	O	998	999	a	a	B-NP	DT	O	32	NMOD	O
O	O	O	1000	1008	dramatic	dramatic	I-NP	JJ	O	32	NMOD	O
O	O	O	1009	1017	increase	increase	I-NP	NN	O	29	PMOD	O
O	O	O	1018	1020	in	in	B-PP	IN	O	32	NMOD	O
T6	B-Protein	B-Protein	1021	1025	PLAP	PLAP	B-NP	NN	B-protein	35	NMOD	B-protein
O	O	O	1026	1034	activity	activity	I-NP	NN	O	33	PMOD	O
O	O	O	1034	1035	.	.	O	.	O	15	P	O

O	O	O	1036	1041	E3330	E3330	B-NP	NN	O	2	SUB	O
O	O	O	1042	1051	inhibited	inhibit	B-VP	VBD	O	0	ROOT	O
O	O	O	1052	1056	this	this	B-NP	DT	O	6	NMOD	O
O	O	O	1057	1064	induced	induce	I-NP	VBN	O	6	NMOD	O
O	O	O	1065	1073	promoter	promoter	I-NP	NN	O	6	NMOD	O
O	O	O	1074	1082	activity	activity	I-NP	NN	O	2	OBJ	O
O	O	O	1083	1085	in	in	B-PP	IN	O	2	VMOD	O
O	O	O	1086	1087	a	a	B-NP	DT	O	12	NMOD	O
O	O	O	1088	1092	dose	dose	I-NP	NN	O	12	NMOD	O
O	O	O	1092	1093	-	-	B-NP	HYPH	O	12	NMOD	O
O	O	O	1093	1102	dependent	dependent	I-NP	JJ	O	12	NMOD	O
O	O	O	1103	1109	manner	manner	I-NP	NN	O	7	PMOD	O
O	O	O	1109	1110	.	.	O	.	O	2	P	O

O	O	O	1111	1116	There	There	B-NP	EX	O	2	SUB	O
O	O	O	1117	1120	are	be	B-VP	VBP	O	0	ROOT	O
O	O	O	1121	1125	four	four	B-NP	CD	O	2	PRD	O
O	O	O	1126	1134	putative	putative	I-NP	JJ	O	10	NMOD	O
T20,T21	B-Entity,B-Entity	B-Entity,B-Entity	1135	1137	NF	NF	I-NP	NN	O	10	NMOD	O
T20,T21	I-Entity,I-Entity	I-Entity,I-Entity	1137	1138	-	-	B-NP	HYPH	O	10	NMOD	O
T20,T21	I-Entity,I-Entity	I-Entity,I-Entity	1138	1143	kappa	kappa	I-NP	NN	B-DNA	10	NMOD	B-DNA
T20,T21	I-Entity,I-Entity	I-Entity,I-Entity	1144	1145	B	B	I-NP	NN	I-DNA	10	NMOD	I-DNA
T20	I-Entity	I-Entity	1146	1153	binding	binding	I-NP	NN	I-DNA	10	NMOD	I-DNA
T20	I-Entity	I-Entity	1154	1159	sites	site	I-NP	NNS	I-DNA	3	NMOD	I-DNA
O	O	O	1160	1161	(	(	O	(	O	31	DEP	O
T22	B-Entity	B-Entity	1161	1166	kappa	kappa	B-NP	NN	B-DNA	30	NMOD	B-DNA
T22	I-Entity	I-Entity	1167	1168	B	B	I-NP	NN	I-DNA	12	NMOD	I-DNA
T22	I-Entity	I-Entity	1168	1169	-	-	B-NP	HYPH	I-DNA	13	NMOD	I-DNA
T22	I-Entity	I-Entity	1169	1170	1	1	I-NP	CD	I-DNA	14	NMOD	I-DNA
O	O	O	1170	1171	,	,	O	,	O	30	P	O
T23	B-Entity	B-Entity	1172	1177	kappa	kappa	B-NP	NN	B-DNA	20	NMOD	B-DNA
T23	I-Entity	I-Entity	1178	1179	B	B	I-NP	NN	I-DNA	20	NMOD	I-DNA
T23	I-Entity	I-Entity	1179	1180	-	-	O	HYPH	I-DNA	20	P	I-DNA
T23	I-Entity	I-Entity	1180	1181	2	2	B-NP	CD	I-DNA	30	NMOD	I-DNA
O	O	O	1181	1182	,	,	O	,	O	30	P	O
T24	B-Entity	B-Entity	1183	1188	kappa	kappa	B-NP	NN	B-DNA	25	NMOD	B-DNA
T24	I-Entity	I-Entity	1189	1190	B	B	I-NP	NN	I-DNA	25	NMOD	I-DNA
T24	I-Entity	I-Entity	1190	1191	-	-	B-NP	HYPH	I-DNA	25	P	I-DNA
T24	I-Entity	I-Entity	1191	1192	3	3	I-NP	CD	I-DNA	30	NMOD	I-DNA
O	O	O	1192	1193	,	,	O	,	O	30	P	O
T25	B-Entity	B-Entity	1194	1199	kappa	kappa	B-NP	NN	B-DNA	30	NMOD	B-DNA
T25	I-Entity	I-Entity	1200	1201	B	B	I-NP	NN	I-DNA	30	NMOD	I-DNA
T25	I-Entity	I-Entity	1201	1202	-	-	B-NP	HYPH	I-DNA	30	P	I-DNA
T25	I-Entity	I-Entity	1202	1203	4	4	I-NP	CD	I-DNA	31	DEP	I-DNA
O	O	O	1203	1204	)	)	O	)	O	3	NMOD	O
O	O	O	1205	1207	in	in	B-PP	IN	O	2	VMOD	O
O	O	O	1208	1213	human	human	B-NP	JJ	B-DNA	37	NMOD	B-DNA
T7	B-Protein	B-Protein	1214	1217	TNF	TNF	I-NP	NN	I-DNA	37	NMOD	I-DNA
T7	I-Protein	I-Protein	1217	1218	-	-	I-NP	HYPH	I-DNA	37	NMOD	I-DNA
T7	I-Protein	I-Protein	1218	1223	alpha	alpha	I-NP	NN	I-DNA	37	NMOD	I-DNA
T26	B-Entity	B-Entity	1224	1232	promoter	promoter	I-NP	NN	I-DNA	32	PMOD	I-DNA
O	O	O	1232	1233	.	.	O	.	O	2	P	O

O	O	O	1234	1236	By	By	B-PP	IN	O	10	VMOD	O
O	O	O	1237	1242	using	use	B-VP	VBG	O	1	PMOD	O
O	O	O	1243	1250	mutated	mutate	B-NP	VBN	B-DNA	7	NMOD	B-DNA
O	O	O	1251	1259	promoter	promoter	I-NP	NN	I-DNA	7	NMOD	I-DNA
O	O	O	1259	1260	-	-	I-NP	HYPH	O	7	P	O
T8	B-Protein	B-Protein	1260	1264	PLAP	PLAP	I-NP	NN	B-DNA	7	NMOD	B-DNA
O	O	O	1265	1273	plasmids	plasmid	I-NP	NNS	I-DNA	2	OBJ	I-DNA
O	O	O	1273	1274	,	,	O	,	O	10	P	O
O	O	O	1275	1277	we	we	B-NP	PRP	O	10	SUB	O
O	O	O	1278	1289	established	establish	B-VP	VBD	O	0	ROOT	O
O	O	O	1290	1294	that	that	B-SBAR	IN	O	10	VMOD	O
O	O	O	1295	1300	these	these	B-NP	DT	O	17	NMOD	O
T27,T28	B-Entity,B-Entity	B-Entity,B-Entity	1301	1303	NF	NF	I-NP	NN	O	17	NMOD	O
T27,T28	I-Entity,I-Entity	I-Entity,I-Entity	1303	1304	-	-	B-NP	HYPH	O	17	NMOD	O
T27,T28	I-Entity,I-Entity	I-Entity,I-Entity	1304	1309	kappa	kappa	I-NP	NN	B-DNA	17	NMOD	B-DNA
T27,T28	I-Entity,I-Entity	I-Entity,I-Entity	1310	1311	B	B	I-NP	NN	I-DNA	17	NMOD	I-DNA
T27	I-Entity	I-Entity	1312	1317	sites	site	I-NP	NNS	I-DNA	18	SUB	I-DNA
O	O	O	1318	1322	were	be	B-VP	VBD	O	11	SBAR	O
O	O	O	1323	1332	necessary	necessary	B-ADJP	JJ	O	18	PRD	O
O	O	O	1333	1336	for	for	B-PP	IN	O	19	AMOD	O
O	O	O	1337	1346	induction	induction	B-NP	NN	O	20	PMOD	O
O	O	O	1347	1349	of	of	B-PP	IN	O	21	NMOD	O
T9	B-Protein	B-Protein	1350	1353	TNF	TNF	B-NP	NN	B-protein	26	NMOD	B-protein
T9	I-Protein	I-Protein	1353	1354	-	-	B-NP	HYPH	O	26	NMOD	O
T9	I-Protein	I-Protein	1354	1359	alpha	alpha	I-NP	SYM	O	26	NMOD	O
O	O	O	1360	1373	transcription	transcription	B-NP	NN	O	22	PMOD	O
O	O	O	1374	1376	on	on	B-PP	IN	O	21	NMOD	O
O	O	O	1377	1388	stimulation	stimulation	B-NP	NN	O	27	PMOD	O
O	O	O	1389	1393	with	with	B-PP	IN	O	28	NMOD	O
O	O	O	1394	1397	LPS	LPS	B-NP	NN	O	29	PMOD	O
O	O	O	1397	1398	.	.	O	.	O	10	P	O

O	O	O	1399	1400	A	A	B-NP	DT	O	4	NMOD	O
O	O	O	1401	1404	gel	gel	I-NP	NN	O	4	NMOD	O
O	O	O	1405	1416	retardation	retardation	I-NP	NN	O	4	NMOD	O
O	O	O	1417	1427	experiment	experiment	I-NP	NN	O	11	SUB	O
O	O	O	1428	1432	with	with	B-PP	IN	O	4	NMOD	O
O	O	O	1433	1442	synthetic	synthetic	B-NP	JJ	O	10	NMOD	O
T29	B-Entity	B-Entity	1443	1449	double	double	I-NP	JJ	O	10	NMOD	O
T29	I-Entity	I-Entity	1449	1450	-	-	I-NP	HYPH	O	10	NMOD	O
T29	I-Entity	I-Entity	1450	1458	stranded	stranded	I-NP	JJ	O	10	NMOD	O
T29	I-Entity	I-Entity	1459	1475	oligonucleotides	oligonucleotide	I-NP	NNS	O	5	PMOD	O
O	O	O	1476	1482	showed	show	B-VP	VBD	O	0	ROOT	O
O	O	O	1483	1487	that	that	B-SBAR	IN	O	11	VMOD	O
O	O	O	1488	1497	activated	activate	B-NP	VBN	O	17	NMOD	O
T30	B-Entity	B-Entity	1498	1500	NF	NF	I-NP	NN	B-protein	17	NMOD	B-protein
T30	I-Entity	I-Entity	1500	1501	-	-	B-NP	HYPH	I-protein	17	NMOD	I-protein
T30	I-Entity	I-Entity	1501	1506	kappa	kappa	I-NP	NN	I-protein	17	NMOD	I-protein
T30	I-Entity	I-Entity	1507	1508	B	B	I-NP	NN	I-protein	24	SUB	I-protein
O	O	O	1509	1519	consisting	consist	B-VP	VBG	O	17	NMOD	O
O	O	O	1520	1522	of	of	B-PP	IN	O	18	VMOD	O
T10	B-Protein	B-Protein	1523	1526	p50	p50	B-NP	NN	B-protein	23	NMOD	B-protein
O	O	O	1526	1527	/	/	B-NP	SYM	O	23	NMOD	O
T11	B-Protein	B-Protein	1527	1530	p65	p65	I-NP	NN	B-protein	23	NMOD	B-protein
T31	B-Entity	B-Entity	1531	1542	heterodimer	heterodimer	I-NP	NN	I-protein	19	PMOD	I-protein
O	O	O	1543	1548	bound	bind	B-VP	VBD	O	12	SBAR	O
O	O	O	1549	1551	to	to	B-PP	TO	O	24	VMOD	O
O	O	O	1552	1555	all	all	B-NP	DT	O	34	NMOD	O
O	O	O	1556	1560	four	four	I-NP	CD	O	34	NMOD	O
O	O	O	1561	1569	putative	putative	I-NP	JJ	O	34	NMOD	O
T32	B-Entity	B-Entity	1570	1572	NF	NF	I-NP	NN	O	34	NMOD	O
T32	I-Entity	I-Entity	1572	1573	-	-	B-NP	HYPH	O	34	P	O
T32	I-Entity	I-Entity	1573	1578	kappa	kappa	I-NP	NN	B-DNA	34	NMOD	B-DNA
T32	I-Entity	I-Entity	1579	1580	B	B	I-NP	NN	I-DNA	34	NMOD	I-DNA
O	O	O	1581	1584	DNA	DNA	I-NP	NN	I-DNA	34	NMOD	I-DNA
O	O	O	1585	1591	probes	probe	I-NP	NNS	I-DNA	25	PMOD	I-DNA
O	O	O	1591	1592	,	,	O	,	O	11	P	O
O	O	O	1593	1603	suggesting	suggest	B-VP	VBG	O	11	VMOD	O
O	O	O	1604	1608	that	that	B-SBAR	IN	O	36	VMOD	O
O	O	O	1609	1612	all	all	B-NP	DT	O	46	NMOD	O
O	O	O	1613	1617	four	four	I-NP	CD	O	46	NMOD	O
O	O	O	1618	1626	putative	putative	I-NP	JJ	O	46	NMOD	O
T33,T34	B-Entity,B-Entity	B-Entity,B-Entity	1627	1629	NF	NF	I-NP	NN	O	46	NMOD	O
T33,T34	I-Entity,I-Entity	I-Entity,I-Entity	1629	1630	-	-	B-NP	HYPH	O	46	NMOD	O
T33,T34	I-Entity,I-Entity	I-Entity,I-Entity	1630	1635	kappa	kappa	I-NP	NN	B-DNA	46	NMOD	B-DNA
T33,T34	I-Entity,I-Entity	I-Entity,I-Entity	1636	1637	B	B	I-NP	NN	I-DNA	46	NMOD	I-DNA
T33	I-Entity	I-Entity	1638	1649	recognition	recognition	I-NP	NN	I-DNA	46	NMOD	I-DNA
T33	I-Entity	I-Entity	1650	1655	sites	site	I-NP	NNS	I-DNA	47	SUB	I-DNA
O	O	O	1656	1660	play	play	B-VP	VBP	O	37	SBAR	O
O	O	O	1661	1663	an	an	B-NP	DT	O	50	NMOD	O
O	O	O	1664	1673	important	important	I-NP	JJ	O	50	NMOD	O
O	O	O	1674	1678	role	role	I-NP	NN	O	47	OBJ	O
O	O	O	1679	1681	in	in	B-PP	IN	O	47	VMOD	O
O	O	O	1682	1691	inducible	inducible	B-NP	JJ	O	56	NMOD	O
T12	B-Protein	B-Protein	1692	1695	TNF	TNF	I-NP	NN	B-protein	56	NMOD	B-protein
T12	I-Protein	I-Protein	1695	1696	-	-	O	HYPH	O	56	NMOD	O
T12	I-Protein	I-Protein	1696	1701	alpha	alpha	B-NP	SYM	O	56	NMOD	O
O	O	O	1702	1712	expression	expression	B-NP	NN	O	51	PMOD	O
O	O	O	1712	1713	.	.	O	.	O	11	P	O

O	O	O	1714	1719	E3330	E3330	B-NP	NN	O	2	SUB	O
O	O	O	1720	1729	decreased	decrease	B-VP	VBD	O	0	ROOT	O
O	O	O	1730	1739	activated	activate	B-NP	VBN	O	7	NMOD	O
T35	B-Entity	B-Entity	1740	1742	NF	NF	I-NP	NN	B-protein	7	NMOD	B-protein
T35	I-Entity	I-Entity	1742	1743	-	-	B-NP	HYPH	I-protein	7	NMOD	I-protein
T35	I-Entity	I-Entity	1743	1748	kappa	kappa	I-NP	NN	I-protein	7	NMOD	I-protein
T35	I-Entity	I-Entity	1749	1750	B	B	I-NP	NN	I-protein	2	OBJ	I-protein
O	O	O	1751	1753	in	in	B-PP	IN	O	7	NMOD	O
O	O	O	1754	1760	nuclei	nucleus	B-NP	NNS	O	8	PMOD	O
O	O	O	1760	1761	,	,	O	,	O	2	P	O
O	O	O	1762	1772	suggesting	suggest	B-VP	VBG	O	2	VMOD	O
O	O	O	1773	1777	that	that	B-SBAR	IN	O	11	VMOD	O
O	O	O	1778	1783	E3330	E3330	B-NP	NN	O	14	SUB	O
O	O	O	1784	1792	inhibits	inhibit	B-VP	VBZ	O	12	SBAR	O
T36	B-Entity	B-Entity	1793	1795	NF	NF	B-NP	NN	B-protein	18	NMOD	B-protein
T36	I-Entity	I-Entity	1795	1796	-	-	I-NP	HYPH	I-protein	18	NMOD	I-protein
T36	I-Entity	I-Entity	1796	1801	kappa	kappa	I-NP	NN	I-protein	18	NMOD	I-protein
T36	I-Entity	I-Entity	1802	1803	B	B	I-NP	NN	I-protein	19	NMOD	I-protein
O	O	O	1804	1814	activation	activation	I-NP	NN	O	23	NMOD	O
O	O	O	1815	1818	and	and	O	CC	O	23	NMOD	O
O	O	O	1818	1819	/	/	B-NP	SYM	O	23	NMOD	O
O	O	O	1819	1821	or	or	O	CC	O	23	NMOD	O
O	O	O	1822	1835	translocation	translocation	B-NP	NN	O	14	OBJ	O
O	O	O	1836	1838	of	of	B-PP	IN	O	23	NMOD	O
O	O	O	1839	1842	the	the	B-NP	DT	O	26	NMOD	O
O	O	O	1843	1849	nuclei	nucleus	I-NP	NNS	O	24	PMOD	O
O	O	O	1849	1850	.	.	O	.	O	2	P	O

O	O	O	1851	1858	Western	Western	B-NP	NN	O	3	NMOD	O
O	O	O	1859	1867	blotting	blotting	I-NP	NN	O	3	NMOD	O
O	O	O	1868	1876	analysis	analysis	I-NP	NN	O	13	SUB	O
O	O	O	1877	1881	with	with	B-PP	IN	O	3	NMOD	O
O	O	O	1882	1886	anti	anti	B-NP	AFX	O	12	NMOD	O
O	O	O	1886	1887	-	-	I-NP	HYPH	O	12	NMOD	O
T13	B-Protein	B-Protein	1887	1888	I	I	I-NP	NN	B-protein	9	NMOD	B-protein
T13	I-Protein	I-Protein	1889	1894	kappa	kappa	I-NP	NN	I-protein	9	NMOD	I-protein
T13	I-Protein	I-Protein	1895	1896	B	B	I-NP	NN	I-protein	12	NMOD	I-protein
T13	I-Protein	I-Protein	1896	1897	-	-	O	HYPH	O	12	NMOD	O
T13	I-Protein	I-Protein	1897	1902	alpha	alpha	O	SYM	O	12	NMOD	O
O	O	O	1903	1911	antibody	antibody	B-NP	NN	O	4	PMOD	O
O	O	O	1912	1921	indicated	indicate	B-VP	VBD	O	0	ROOT	O
O	O	O	1922	1926	that	that	B-SBAR	IN	O	13	VMOD	O
O	O	O	1927	1932	E3330	E3330	B-NP	NN	O	16	SUB	O
O	O	O	1933	1942	inhibited	inhibit	B-VP	VBD	O	14	SBAR	O
O	O	O	1943	1954	degradation	degradation	B-NP	NN	O	16	OBJ	O
O	O	O	1955	1957	of	of	B-PP	IN	O	17	NMOD	O
T14	B-Protein	B-Protein	1958	1959	I	I	B-NP	NN	B-protein	21	NMOD	B-protein
T14	I-Protein	I-Protein	1960	1965	kappa	kappa	I-NP	NN	I-protein	21	NMOD	I-protein
T14	I-Protein	I-Protein	1966	1967	B	B	I-NP	NN	I-protein	23	NMOD	I-protein
T14	I-Protein	I-Protein	1967	1968	-	-	O	HYPH	O	23	P	O
T14	I-Protein	I-Protein	1968	1973	alpha	alpha	B-NP	SYM	O	18	PMOD	O
O	O	O	1973	1974	,	,	O	,	O	23	P	O
O	O	O	1975	1980	which	which	B-NP	WDT	O	23	NMOD	O
O	O	O	1981	1983	is	be	B-VP	VBZ	O	25	SBAR	O
O	O	O	1984	1986	an	an	B-NP	DT	O	29	NMOD	O
O	O	O	1987	1997	inhibitory	inhibitory	I-NP	JJ	B-protein	29	NMOD	B-protein
O	O	O	1998	2005	protein	protein	I-NP	NN	I-protein	26	PRD	I-protein
O	O	O	2006	2008	of	of	B-PP	IN	O	29	NMOD	O
T37	B-Entity	B-Entity	2009	2011	NF	NF	B-NP	NN	B-protein	34	NMOD	B-protein
T37	I-Entity	I-Entity	2011	2012	-	-	B-NP	HYPH	I-protein	34	NMOD	I-protein
T37	I-Entity	I-Entity	2012	2017	kappa	kappa	I-NP	NN	I-protein	34	NMOD	I-protein
T37	I-Entity	I-Entity	2018	2019	B	B	I-NP	NN	I-protein	30	PMOD	I-protein
O	O	O	2019	2020	,	,	O	,	O	23	P	O
O	O	O	2021	2023	in	in	B-PP	IN	O	16	VMOD	O
O	O	O	2024	2027	LPS	LPS	B-NP	NN	O	40	NMOD	O
O	O	O	2027	2028	-	-	B-NP	HYPH	O	40	P	O
O	O	O	2028	2038	stimulated	stimulate	I-NP	VBN	O	40	NMOD	O
O	O	O	2039	2048	monocytes	monocyte	I-NP	NNS	B-cell_type	36	PMOD	B-cell_type
O	O	O	2048	2049	.	.	O	.	O	13	P	O

O	O	O	2050	2055	E3330	E3330	B-NP	NN	O	2	SUB	O
O	O	O	2056	2059	may	may	B-VP	MD	O	0	ROOT	O
O	O	O	2060	2068	suppress	suppress	I-VP	VB	O	2	VC	O
O	O	O	2069	2072	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	2073	2083	production	production	I-NP	NN	O	3	OBJ	O
O	O	O	2084	2086	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	2087	2093	active	active	B-NP	JJ	O	9	NMOD	O
O	O	O	2094	2100	oxygen	oxygen	I-NP	NN	O	9	NMOD	O
O	O	O	2101	2108	species	specie	I-NP	NNS	O	6	PMOD	O
O	O	O	2109	2116	serving	serve	B-VP	VBG	O	9	NMOD	O
O	O	O	2117	2119	as	as	B-PP	IN	O	10	VMOD	O
O	O	O	2120	2126	common	common	B-NP	JJ	O	13	NMOD	O
O	O	O	2127	2137	messengers	messenger	I-NP	NNS	O	11	PMOD	O
O	O	O	2138	2140	to	to	B-VP	TO	O	15	VMOD	O
O	O	O	2141	2149	activate	activate	I-VP	VB	O	2	VMOD	O
T38	B-Entity	B-Entity	2150	2152	NF	NF	B-NP	NN	B-protein	19	NMOD	B-protein
T38	I-Entity	I-Entity	2152	2153	-	-	B-NP	HYPH	I-protein	19	NMOD	I-protein
T38	I-Entity	I-Entity	2153	2158	kappa	kappa	I-NP	NN	I-protein	19	NMOD	I-protein
T38	I-Entity	I-Entity	2159	2160	B	B	I-NP	NN	I-protein	15	OBJ	I-protein
O	O	O	2160	2161	.	.	O	.	O	2	P	O
